876377-82-1

Basic information

• Product Name: Carbamic acid, [(3S)-1-[(3-chloro-2-methylphenyl)sulfonyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
• CAS NO: 876377-82-1
• Molecular Formula: C17H25ClN2O4S
• Molecular Weight: 388.915
• Mol File: 876377-82-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(3S)-1-[(3-chloro-2-methylphenyl)sulfonyl]-3-piperidinyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(3S)-1-[(3-chloro-2-methylphenyl)sulfonyl]-3-piperidinyl]-, 1,1-dimethylethyl ester(876377-82-1)
• EPA Substance Registry System: Carbamic acid, [(3S)-1-[(3-chloro-2-methylphenyl)sulfonyl]-3-piperidinyl]-, 1,1-dimethylethyl ester(876377-82-1)

Safety Data

• Hazardous Substances Data: 876377-82-1(Hazardous Substances Data)

Upstream product

• 80563-86-6 3-chloro-2-methylbenzenesulfonyl chloride 
• 216854-23-8 tert-butyl (S)-piperidin-3-yl-carbamate 

Downstream Products

• 876377-83-2 (3S)-1-[(3-chloro-2-methylphenyl)sulfonyl]piperidin-3-amine 
• 1056998-47-0 (3S)-1-[(3-Chloro-2-methylphenyl)sulfonyl]piperidin-3-amine hydrochloride 

Relevant articles and documents

AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS

The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.

Amido compounds and their use as pharmaceuticals

The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor MR, and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.